Columbia Asset Management Edwards Lifesciences Corp Transaction History

Columbia Asset Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$83.84 - $104.76 $5,030 - $6,285	-60 Reduced 1.99%	2,960 $307,000
Q1 2021 May 28, 2021	BUY	$78.68 - $90.67 $27,538 - $31,734	350 Added 13.11%	3,020 $253,000
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $15,117 - $19,674	-225 Reduced 7.77%	2,670 $213,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $75,665 - $101,189	1,315 Added 83.23%	2,895 $200,000
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $50,051 - $77,355	-955 Reduced 37.67%	1,580 $298,000
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $2,509 - $2,873	35 Added 1.4%	2,535 $5.91 Million
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $24,927 - $30,549	-405 Reduced 13.94%	2,500 $550,000
Q2 2019 Aug 15, 2019	BUY	$55.74 - $64.41 $161,924 - $187,111	2,905 New	2,905 $537,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

Stay updated on Columbia Asset Management with notifications on news.